Percutaneous Nephrolithotomy Global Market Report 2024

Percutaneous nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove kidney stones (renal calculi) from the urinary tract. This procedure involves making a small incision in the skin and creating a direct channel to the kidney through which instruments are inserted to break up and extract the stones. PCNL is employed when other less invasive methods, such as shock wave lithotripsy or ureteroscopy, are ineffective or unsuitable.

The main types of kidney stones treated by percutaneous nephrolithotomy include magnesium ammonium phosphate stones, calcareous stones, and uric acid calculi. Magnesium ammonium phosphate (MAP) stones are composed of magnesium, ammonium, and phosphate ions. The components involved in PCNL include accessories, devices, and services, which are utilized by end users such as ambulatory surgical centers, clinics, and hospitals.

The percutaneous nephrolithotomy market research report is one of a series of new reports that provides percutaneous nephrolithotomy market statistics, including the percutaneous nephrolithotomy industry global market size, regional shares, competitors with percutaneous nephrolithotomy market share, detailed percutaneous nephrolithotomy market segments, market trends, and opportunities, and any further data you may need to thrive in the percutaneous nephrolithotomy industry. These percutaneous nephrolithotomy market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The percutaneous nephrolithotomy market size has grown strongly in recent years. It will grow from $16.49 billion in 2023 to $17.9 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed in the historic period can be attributed to several factors, including the increasing prevalence of kidney stones, rising demand for effective and efficient treatment options for kidney stones, expansion of healthcare infrastructure in emerging economies, an aging population leading to a higher incidence of kidney stones, a surge in research and development activities, increasing healthcare expenditure, and a growing emphasis on patient-centric healthcare.

The percutaneous nephrolithotomy market size is expected to see strong growth in the next few years. It will grow to $25.15 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The expected growth in the forecast period can be attributed to several factors, including the growing adoption of minimally invasive surgical procedures, rising demand for effective stone removal techniques, increasing awareness about the benefits of percutaneous nephrolithotomy, a growing geriatric population prone to kidney stone formation, the increasing availability of advanced medical technologies for stone removal, a rising focus on patient-centric care, and an increasing preference for outpatient procedures. Major trends anticipated during this period include the adoption of miniaturized instruments, advancements in imaging technologies, implementation of robotics, adoption of disposable devices, advancements in stone retrieval devices, improvements in anesthesia techniques, implementation of enhanced infection control measures, adoption of multimodal pain management, and the development of training programs.

The increasing prevalence of renal diseases is set to drive the growth of the percutaneous nephrolithotomy market in the coming years. Renal diseases encompass a variety of conditions affecting the kidneys and hindering their proper functioning. Factors contributing to the prevalence of renal diseases include rising rates of diabetes and hypertension, an aging population, lifestyle choices, genetic factors, chronic conditions, and improved awareness and diagnosis. Percutaneous nephrolithotomy plays a crucial role in managing renal diseases by offering a minimally invasive surgical procedure to remove large or complex kidney stones, alleviate pain, prevent urinary tract infections, and enhance kidney function. For example, a UK-based Kidney Research Commission reported in June 2023 that kidney disease affected 7.19 million people in the UK in 2023 and is projected to increase to 7.61 million by 2033. Hence, the increasing prevalence of renal diseases is fueling growth in the percutaneous nephrolithotomy market.

Leading companies in the percutaneous nephrolithotomy market are concentrating on implementing innovative solutions, such as robot-assisted surgical platforms, to improve surgical precision and patient outcomes. A robot-assisted surgical platform is an advanced medical system utilizing robotic technology to aid surgeons in performing complex procedures with enhanced precision, control, and flexibility. For instance, Ethicon Inc., a US-based Johnson & Johnson MedTech company, announced in February 2023 the successful robotic-assisted removal of kidney stones in the first patient using the MONARCH Platform for urology. This platform enables urologists to navigate the kidney with robotic assistance, facilitating access, clearance, and control via a handheld controller. It offers a unified platform supporting ureteroscopic and percutaneous nephrolithotomy (PCNL) procedures, delivering enhanced navigation, access, clearance, and control compared to traditional methods.

In March 2021, Boston Scientific, a US-based medical device manufacturing company, acquired Lumenis Ltd. The acquisition aims to bolster Boston Scientific's presence in the global surgical market, particularly in urology and otolaryngology procedures. Additionally, it incorporates Lumenis' innovative MOSES technology, known for improving clinical outcomes in kidney stone management. Lumenis Ltd. is an Israel-based energy-based medical device company specializing in developing and manufacturing laser and light-based systems for various medical applications, including percutaneous nephrolithotomy (PCNL).

Major companies operating in the percutaneous nephrolithotomy market are Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Olympus Corporation, Terumo Corporation, Coloplast Corporation, B. Braun, Cook Medical, Teleflex Incorporated, Karl Storz Se And Co. KG, Merit Medical Systems, Richard Wolf GmbH, AngioDynamics, Argon Medical Devices, Dornier MedTech, EDAP TMS, Allengers Medical Systems Limited, DirexGroup, Envaste Limited, ELMED Lithotripsy Systems, PolyDiagnost, Attikouris Enterprises Ltd., Advin Urology, Avenda Health, Guangzhou Potent Optotronic Technology Co. Ltd., Surgimedik.

North America was the largest region in the percutaneous nephrolithotomy market in 2023. The regions covered in the percutaneous nephrolithotomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the percutaneous nephrolithotomy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The percutaneous nephrolithotomy market consists of revenues earned by entities by providing services such as preoperative consultation and assessment, imaging services, anesthesia services, and postoperative care. The market value includes the value of related goods sold by the service provider or included within the service offering. The percutaneous nephrolithotomy market also includes sales of nephroscopes, lithotripters, and guidewires. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.